by APFLI | Nov 13, 2005 | Studies - RU486 / Chemical Abortion / Maternal Mortality
“Elective Medical Abortion and Maternal Mortality” is a summary of research on the relationship between medical or chemical abortion (RU 486, or Mifeprex) and maternal mortality (death of the pregnant woman). Click here to view this presentation....
by APFLI | Aug 4, 2005 | Abortion (New)
CDC NEJM Article Warns of Abortion Drug Risks Italy Health Minister Stops RU-486 Abortion Drug Trials After Problems RU-486 Maker Sued After 21-Year-Old Dies FDA Issues Warning About Deadly Infections from Mifeprex Abortion Pill Lawmakers want Mifeprex Pulled After...
by APFLI | Aug 22, 2004 | General Information / History / Stats / Types
It is essential for a doctor or pregnancy counselor to understand the dangers involved in a mifeprex abortion. This paper will cover: l. How Mifeprex works 2. the Mifeprex program 3. The usual clinical course 4. Complications and dangers of the Mifeprex abortion...
by APFLI | Mar 11, 2004 | Responses - Defending Life / Rebuttals / Advocacy / Dating / Adoption
As I sit here writing this at one o’clock in the morning, I’m trying to analyze why I’ve left this page until last. Denial isn’t a factor at this point, I’ve come to a realization of what I’ve done. I think a little more about it...
by APFLI | Mar 9, 2004 | General Information / History / Stats / Types
On September 28, 2000, the United States Food and Drug Administration (FDA) announced the approval of mifepristone, in combination with misoprostol, for early pregnancy termination. This decision received the enthusiastic approval of the American College of...